PENIMIXCINA
- Product NDC
- 69729-615
- 11-digit product format
- 697290615
- Labeler code
- 69729
- Product ID
- 69729-615_18ae5c8b-2507-fac3-e063-6394a90a6072
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- OPMX LLC
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-09-05
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500; 5; 5000; 10 [iU]/g; mg/g; [iU]/g; mg/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 69729-615-05 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 69729-615-05 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 69729-615-05 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 69729-615-05 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 69729-615-05 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 69729-615-05 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 69729-615-05 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 69729-615-05 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PENIMIXCINA
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 500 [iU]/g |
| NEOMYCIN SULFATE | 5 mg/g |
| POLYMYXIN B SULFATE | 5000 [iU]/g |
| PRAMOXINE HYDROCHLORIDE | 10 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
| 88AYB867L5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2055751 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 92bcbc02-9683-4117-af2b-6d4687796f1f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| 58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8 | Product name | 1 | 20140508 |
| a7051cba-790b-a699-81f8-dbbbdbd9b5ac | Product name | 1 | 20140508 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
| da108d9e-edc8-17a3-8c28-3251c6a8accc | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-05-19 | Penimixcina - First Aid Ointment |
| 2024-01-30 | Penimixcina - First Aid Ointment |
| 2022-10-19 | Penimixcina - First Aid Ointment |
| 2020-01-31 | Penimixcina - First Aid Ointment |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69729-615-01 | PENIMIXCINA | 14 g in 1 TUBE | OINTMENT | 14 | 5 | |
| 69729-615-05 | PENIMIXCINA | 1 in 1 BOX | OINTMENT | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Bacitracin Zinc | BACITRACIN ZINC | Cardinal Health 110 dba LEADER | a353dce2-8ae5-23aa-e053-2a95a90a89c2 | 2024-01-02 | Warnings | M004 |
| Triple Antibiotic | POLYMYXIN B SULFATE, BACITRACIN ZINC AND NEOMYCIN SULFATE | NuCare Pharmaceuticals,Inc. | 0dfe5f6a-6968-68e6-e063-6294a90ae25b | 2024-01-02 | Warnings | M004 |
| Bacitracin | BACITRACIN | Proficient Rx LP | e1166948-5d80-44c2-a20d-78be631647d9 | 2024-01-01 | Warnings | M004 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Proficient Rx LP | 949c5b44-ee52-4913-8872-39181d319998 | 2024-01-01 | Warnings | M004 |
| Triple Antibiotic Plus | POLYMYXIN B SULFATE, BACITRACIN ZINC, NEOMYCIN SULFATE, PRAMOXINE HCL | Cosette Pharmaceuticals, Inc. | 69d911c2-cb89-2241-35f8-c83acfe18249 | 2023-12-21 | Warnings | M004 |
| Bacitracin | BACITRACIN | Cosette Pharmaceuticals, Inc. | 630e0841-baf2-e9fa-b309-ad1a5f95da3b | 2023-12-20 | Warnings | M004 |
| Triple Antibiotic | POLYMYXIN B SULFATE, BACITRACIN ZINC AND NEOMYCIN SULFATE | Cosette Pharmaceuticals, Inc. | 39893365-c94f-bc83-67f6-0005d5f2aa24 | 2023-12-20 | Warnings | M004 |
| Triple Antibiotic | POLYMYXIN B SULFATE, BACITRACIN ZINC AND NEOMYCIN SULFATE | Proficient Rx LP | 524d65e7-9dc6-47b0-a924-46a765fa1869 | 2023-12-01 | Warnings | M004 |
| Viabecline | TETRACYCLINE HYDROCHLORIDE | Accuria, LLC | 9fd7041a-6c23-4332-90fe-759bb4aea2ae | 2023-12-01 | Warnings | M004 |
| Bacitracin | BACITRACIN | Proficient Rx LP | 65f8fd49-1882-4eac-9c0e-d63968da33d4 | 2023-12-01 | Warnings | M004 |
| Genuine First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | GFA Production(Xiamen) Co.,Ltd | 0aaee474-cf35-8b39-e063-6294a90a815c | 2023-11-21 | Warnings | M004 |
| Sheffield Bacitracin Zinc | BACITRACIN ZINC | Sheffield Pharmaceuticals LLC | 0f446f48-f55d-4de7-b447-285d7a329c84 | 2023-11-20 | Warnings | M004 |
| Sheffield Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, PRAMOXINE HYDROCHLORIDE | Sheffield Pharmaceuticals LLC | 485a779c-017b-4064-a446-e5073c1bdb07 | 2023-11-20 | Warnings | M004 |
| Bacitracin | BACITRACIN | BluePoint Laboratories | b4d8ef06-6269-68f7-e053-2995a90ac8ea | 2023-11-17 | Warnings | M004 |
| Bacitracin Zinc | FIRST AID ANTIBIOTIC | BluePoint Laboratories | d914abe1-5e14-5673-e053-2a95a90ac91b | 2023-11-17 | Warnings | M004 |
| EVERLIT CARE Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | EVERLIT GLOBAL INC. | e9157891-fc05-41a1-8a86-761a9ae56f8a | 2023-11-14 | Warnings | M004 |
| CR-371059 Tolnaftate 1% | CR-371059 TOLNAFTATE 1% | A-S Medication Solutions | bb4e4612-850c-4863-954d-7ad0500b9c05 | 2023-11-01 | Warnings | M004 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | A-S Medication Solutions | b44b07a0-91ff-476a-ae0a-080fa0191777 | 2023-10-31 | Warnings | M004 |
| Family wellness | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | FRONT PHARMACEUTICAL PLC | bd3b8146-6271-488d-bf79-0bb659123b31 | 2023-10-27 | Warnings | M004 |
| Family Wellness | BACITRACIN ZINC | FRONT PHARMACEUTICAL PLC | dfc148c1-d1bb-4230-b8cf-9457b99d4e8a | 2023-10-27 | Warnings | M004 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2055751 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT / pramoxine HCl 10 MG per GM Topical Ointment | PSN | 92bcbc02-9683-4117-af2b-6d4687796f1f | 5 |
| 2055751 | bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment | SCD | 92bcbc02-9683-4117-af2b-6d4687796f1f | 5 |
| 2055751 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT / pramoxine HCl 10 MG per GM Topical Ointment | SY | 92bcbc02-9683-4117-af2b-6d4687796f1f | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69729-615-01 | 69729061501 | 14 g in 1 TUBE | 14 g | Historical | ||||
| 69729-615-05 | 69729061505 | 1 TUBE in 1 BOX (69729-615-05) / 14 g in 1 TUBE (69729-615-01) | 1 tube | 2018-09-05 | 0000-00-00 | No | No | Current |